Anti-asthmatic composition and method using 5,8,11,14- eicosatetraenoic acid
CA 1283860 C · Owner: Rubin, David · Inventors: Rubin, David
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A method for the treatment of asthma nasal congestion and, anaphylactic shock involves nasal or oral administration of 8,11,14,17eicosatetraenoic acid. Pharmaceutical compositions for this purpose are prepared containing 8,11,14,17-eicosatetraenoic acid and pharmaceutically acceptable vehicles, as well as preferably, a suitable, anti-oxidant.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted May 7, 1991. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended May 7, 2008.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.